The ‘Freestyle Libre’, from the healthcare firm Abbott, is currently the only flash glucose sensing device in existence.
The device will, subject to local health authority approval, be available on the NHS across the United Kingdom from 1st November 2017.
Flash glucose sensing is a recent development in glucose monitoring. It uses a sensor the size of a £2 coin and sits on the back of the arm with a probe just under the skin.
By ‘flashing’ the sensor with a scanning device, the user receives a blood glucose level reading, a graph of blood glucose levels for the previous eight hours and a direction arrow showing if their levels are going up or down.
Evidence shows that flash glucose monitoring can help people with type 1 diabetes manage their condition and keep in good health.
Of today’s news, Karen Addington, JDRF’s UK Chief Executive said:
“Today’s announcement is good news for people living with type 1 diabetes. But it is vital that the technology actually reaches those who want it and would benefit. There is a postcode lottery of NHS provision of type 1 diabetes technology. This is despite such devices making daily life with type 1 diabetes much easier.
“Each and every person with type 1 diabetes who wants this technology, and would benefit, should receive it. JDRF will continue to campaign in Westminster and devolved governments on this issue.”
JDRF has produced a guide to type 1 diabetes technology, which highlights recommendations from The National Institute for Health and Care Excellence (NICE) on treatments and technology for children and adults. To view the guide please click here.
The UK charity INPUT has a mission to help people gain access to diabetes technology. Find out more here.
Abbott’s customer service line can answer your questions. Find out more about getting in touch with Abbott here.